Caplight Directory>Companies>Salient Bio-preview>Salient


Salient Bio

Salient Bio

Private
LondonHealthcare & Life Scienceshttps://salient.bio

Last Round

Seed

Sep 3, 2025

Total Funding Raised

$3.15M

Momentum Score

25 /100

Company Overview

Salient Bio is a biotechnology company that operates a diagnostic laboratory intended to broaden access to medical testing by integrating synthetic biology and robotics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Healthcare Analytics, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware + Subscription, Data as a Service

AI Layer

Application

Keywords

microbiome analysismicrobiome diagnosticspathology servicesat-home diagnosticsnon-invasive diagnosticsIBD diagnosticIBDlab automationAI diagnosticslab-as-a-servicegut health testing16S sequencingshotgun sequencingmetabolomicsprecision medicineclinical trial serviceswomen's health diagnosticsdigital health portalsample collection kits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Salient Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Salient Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 3, 2025
View all Funding Rounds

Salient Bio Investors

Notable investors and investment history

InvestorRounds
THENA CapitalSeed
View all Investors

Salient Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Salient Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Salient Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range19
Year Founded2020
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.